People who bought Propidren Hair Growth Dietary Supplement may be covered by a proposed class action alleging HairGenics falsely markets the capsules as “clinically proven” to stop hair loss and regrow hair when no clinical trial of the product exists. No class has been certified and there is nothing to file yet.
Allegations Only · No Settlement Yet
This article describes a class action complaint. The statements below are unproven allegations. HairGenics LLC has not been found liable, there is no certified class, and nothing to claim at this time. This page is informational and is not legal advice.
What Is the Propidren Lawsuit?
A proposed class action filed on September 24, 2026, in the U.S. District Court for the Central District of California challenges the advertising for Propidren Hair Growth Dietary Supplement, a capsule sold largely through Amazon. The case is Saks v. HairGenics LLC, No. 2:26-cv-11068. HairGenics, which the complaint describes as a Delaware company based in Las Vegas that does business under the Propidren brand, is the only defendant.The complaint alleges that the product’s packaging, Amazon listing and other marketing claim it regrows hair, stops and prevents hair loss, blocks DHT and contains “clinically proven” ingredients, and that those claims are not just unsupported but false. The plaintiff, a Los Angeles County resident, says she bought a bottle on Amazon in October 2023 for $49.27 after reading the listing. She demands a jury trial. No court has ruled on any of the allegations.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
The Advertising Claims Being Challenged
The complaint quotes 14 statements from the Propidren packaging and Amazon listing that it calls the “Advertised Claims.” They include:- “Stimulates Follicles to Regrow Hair”
- “Saw Palmetto is Clinically Proven to Help Stop Hair Loss and to Induce Hair Regrowth”
- “Clinically Proven to Stop Hair Loss and Help Regrow and Thicken Hair”
- “Formulated by Doctors to Regrow Hair”
- “Start Seeing Hair Growth in 60 Days”
- “Prevents and Reverses Hair Loss”
- “100% Safe and Effective”
The plaintiff alleges that she read and relied on the hair regrowth and “clinically proven” claims, and that comparable supplements without those claims sold for less, so she paid a premium she would not have paid had she known the truth.
Why the Lawsuit Says the Claims Are False
The complaint makes four main arguments:- No clinical trial: it alleges no clinical trial of Propidren has ever been conducted and that the advertising cites no study or investigator, so a “clinically proven” claim asserts proof that does not exist.
- Saw palmetto: it cites the National Center for Complementary and Integrative Health, part of the U.S. Department of Health and Human Services, which found the evidence on saw palmetto for male-pattern hair loss “too limited to allow conclusions to be reached.” It adds that the studies reporting any effect used standardized extracts, while Propidren’s Supplement Facts panel lists only “Saw Palmetto (Serenoa repens)(fruit) 200 mg” with no extract or standardization stated.
- Biotin: it cites research, dating back to a 1965 study, finding that biotin supplementation lacks sufficient evidence of benefit for hair in people who are not biotin deficient.
- Drug claims: it argues that marketing the capsules as a treatment that prevents, stops and reverses hair loss makes Propidren an unapproved new drug that is misbranded under federal and California law.
The complaint notes that the FDA has approved two drugs for male-pattern hair loss, topical minoxidil and oral finasteride, and that dietary supplements are not reviewed by the agency for effectiveness before sale. It says the plaintiff is not claiming that FDA approval was required to sell Propidren as a supplement, only that the product was marketed with the language of clinical proof without the evidence behind it.
Who Is in the Proposed Class?
The complaint proposes two groups:- Nationwide Class: all persons in the United States who, within the applicable limitations period, purchased the product for personal, family or household use and not for resale.
- California Subclass: all persons who, within the applicable limitations period, purchased the product in California for the same purposes.
HairGenics and its officers, directors and employees, and the judges assigned to the case, are excluded. Both definitions are proposals only. A judge would have to certify a class before anyone is formally part of the case, and the definitions can change before then.
Legal Claims and What the Lawsuit Seeks
The complaint brings six claims:- Violation of California’s Consumers Legal Remedies Act (California Subclass)
- Violation of California’s Unfair Competition Law (California Subclass)
- Violation of California’s False Advertising Law (California Subclass)
- Breach of express warranty (both classes)
- Unjust enrichment (both classes)
- Violation of Nevada’s Deceptive Trade Practices Act (nationwide class)
The nationwide claim is brought under Nevada law because, the complaint says, HairGenics is based in Las Vegas and its marketing decisions were made there. The lawsuit asks the court to certify the classes and seeks compensatory, statutory and punitive damages, restitution, an order stopping the challenged claims and requiring corrective advertising, interest, and attorneys’ fees and costs. Those are the plaintiff’s requests, not amounts anyone has been awarded.
What Happens Next
HairGenics will respond to the complaint. Supplement advertising cases are often challenged at the outset on whether the plaintiff has shown the claims are false rather than merely unproven, a line the complaint addresses directly by arguing that a “clinically proven” claim is false when no clinical test exists. If the case survives, the parties exchange evidence and the plaintiff can ask the court to certify the classes. The case could also settle at any stage.Buyers do not need to do anything now. There is no claim form, and nothing is required to stay within a proposed class. If the case settles or a class is certified, class members are normally notified and told how to file a claim or opt out. Other supplement marketing cases pending in court include a suit over Lemme’s GLP-1 Daily supplement.
Questions
Can I get a refund from the Propidren lawsuit right now?
No. The case was filed on September 24, 2026 and is at the complaint stage. No class has been certified, there is no settlement or judgment, and there is no claim form. HairGenics has not been found liable. Money would only become available if the case later settles or the plaintiff wins.
Who is in the proposed Propidren class?
The complaint proposes a nationwide class of everyone in the United States who bought Propidren Hair Growth Dietary Supplement for personal, family or household use within the applicable limitations period, and a California Subclass of people who bought it in California. Buyers who purchased for resale are excluded. These are proposed definitions only; a judge has not certified either group.
Does the lawsuit say Propidren is unsafe?
The complaint is about advertising, not injuries. It alleges the hair regrowth and hair loss claims are false and challenges the label’s “100% Safe and Effective” statement as part of those advertising claims. It also argues that marketing a supplement as a treatment that prevents and reverses hair loss makes it an unapproved new drug under federal and California law. It does not allege that anyone was physically harmed.
Why does the complaint focus on saw palmetto and biotin?
Many of the challenged claims rest on those two ingredients. The complaint says a federal review of saw palmetto research found the evidence for hair loss too limited to draw conclusions, and that the studies reporting any effect used standardized extracts, while Propidren’s label lists only 200 mg of saw palmetto fruit. On biotin, it cites research finding insufficient evidence that supplementation helps hair growth in people who are not biotin deficient.
What happens next in the Propidren case?
HairGenics will respond to the complaint, often with a motion to dismiss some or all of the claims. If the case survives, the parties exchange evidence and the plaintiff can ask the court to certify the proposed classes. The case could also settle at any stage. Buyers do not need to do anything now to remain within the proposed class.
Sources
• Class Action Complaint, Saks v. HairGenics LLC, No. 2:26-cv-11068 (C.D. Cal., filed September 24, 2026), Document 1: Propidren class action complaint (PDF).• Saks v. HairGenics LLC docket on CourtListener.
• National Center for Complementary and Integrative Health: Saw Palmetto.
